ESR2 and breast carcinoma: On the other hand, owing to challenges in detection due to decreased protein expression, the use of non-specific antibodies, and the contribution of alternatively spliced and differentially expressed isoforms to the immunohistochemical signal, initial reports of ERβ action and clinical importance in breast cancer were conflicting.